Drug Eye Africa

ANAMEV trains technical staff on medicine marketing authorisation evaluation

The Agence Nationale des Médicaments et des Évacuations Sanitaires (ANAMEV) has completed a four-day internal technical training on the evaluation of marketing authorisation (AMM) dossiers.

The session ran from 21 to 24 September 2026 and was led by Dr Assoumani Mahamoud, a pharmacist specialist in pharmaceutical regulation. It focused on administrative and regulatory evaluation and quality control of medicines.

The training established a clear distinction between the phases of dossier admissibility and selection, with a standardised and traceable administrative analysis methodology. A principle of deadline suspension in cases of identified inaccuracy was introduced to ensure completeness and compliance before expert committee review.

The programme also covered clarification of tracking tools and reporting to the National Commission, in a continuous improvement framework. Sessions combined theoretical instruction with practical immersion exercises.

ANAMEV stated the training marks an important step in its mission to ensure the Comorian population has access to safe, effective and quality pharmaceutical products.

Source: Agence Nationale des Médicaments et des Évacuations Sanitaires (ANAMEV), “Formation interne : l’ANAMEV renforce les capacités de son équipe technique pour l’homologation des médicaments”, 25 September 2026: https://www.anamev.org/actualite.php?id=35

About the author

Drug Eye Africa Newsroom

Drug Eye Africa Newsroom

The Drug Eye Africa newsroom reports on medicines regulation, recalls and medicine quality across the African continent. Alerts are matched against the issuing authority's published notice before publication, and corrections are timestamped on the article rather than made silently.

Regulatory alerts and news, direct to your inbox

Independent pharmaceutical news and regulatory intelligence covering Africa.

Scroll to Top